Insider sales of common stock — Repare Therapeutics (NASDAQ: RPRX)

Rhea-AI Filing Summary

Repare Therapeutics related entities reported multiple sales of common stock under a Form 144. The excerpt lists transactions by GWL 2013 NG LLC and GWL 2014 G LLC on several dates in December 2025 through February 2026.

Examples shown include 123,965 shares sold on 01/21/2026 and 110,000 shares sold on 12/03/2025. The filing records dollar proceeds for each sale in the excerpt.

Insights

Securities Compliance Analyst

Transactions are routine Rule 144 resale notices listing multiple block sales by affiliated holders.

The excerpt lists specific resale transactions of common stock attributed to entities named GWL 2013 NG LLC and GWL 2014 G LLC, with trade dates from 12/03/2025 through 02/19/2026

These entries appear as regulatory disclosures rather than company actions; timing and settlement details beyond the trade dates are not shown in the excerpt.

Equity Markets Specialist

Sale sizes are material at the trade level but the excerpt does not aggregate totals or show ownership context.

The filing shows individual transactions such as 123,965 shares on 01/21/2026 and 110,000 shares on 12/03/2025, with associated proceeds in dollars listed per row.

Impact on outstanding float or ownership concentration is not provided in the excerpt; subsequent disclosures would be required to assess market impact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	136980	6496961.4	428418612	03/04/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/16/2020	Acquired from issuer in private transaction	Issuer			136980	06/16/2020	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GWL 2013 NG LLC 110 East 59th Street New York NY 10022	Common Stock	01/21/2026	123965	4913885.82
GWL 2014 G LLC 110 East 59th Street New York NY 10022	Common Stock	12/03/2025	110000	4375008
GWL 2014 G LLC 110 East 59th Street New York NY 10022	Common Stock	12/17/2025	79346	3060280
GWL 2013 NG LLC 110 East 59th Street New York NY 10022	Common Stock	01/07/2026	123965	5093114.42
GWL 2013 NG LLC 110 East 59th Street New York NY 10022	Common Stock	02/18/2026	74712	3372604.28
GWL 2013 NG LLC 110 East 59th Street New York NY 10022	Common Stock	02/04/2026	123965	5383105.75
GWL 2014 G LLC 110 East 59th Street New York NY 10022	Common Stock	12/18/2025	30654	1180053.32
GWL 2013 NG LLC 110 East 59th Street New York NY 10022	Common Stock	02/19/2026	49253	2217818.26

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for RPRX disclose?

The form disclosed multiple resale transactions of common stock by affiliated holders. The excerpt lists sales by GWL entities with trade dates from December 2025 through February 2026 and dollar proceeds per sale.

Who sold shares according to the RPRX Form 144 excerpt?

Entities named GWL 2013 NG LLC and GWL 2014 G LLC are listed as sellers. The excerpt shows those entities executing multiple common stock sales on the dates provided.

How many shares were sold in the listed transactions?

Individual transactions shown include 123,965 shares and 110,000 shares among others. The excerpt presents per-trade share counts and corresponding dollar proceeds for each row.

Does the filing state proceeds treatment or company involvement?

The excerpt records dollar proceeds for each sale but does not state company receipt of proceeds. The entries read as resale transactions by the named holders rather than issuer proceeds statements.

Are aggregate totals or shares outstanding shown in the excerpt?

The excerpt provides per-transaction share counts and proceeds but does not present an aggregate total or a shares-outstanding figure tied to an "as of" date in the provided text.